Tate and smile!

First a quick shout out to subscriber SoupChicken for their gracious comments on Tate & Lyle (TATE) earlier in the comment section of another story. Latest numbers from the sugars and ingredients company crystalised(!) many of the hopes I put out in my February update, which you can read HERE. As I noted back then '...for punters the 550s is one level to write down' and boy did that work from the sentiment lows in late March with the shares now breaking 650p. So that's great...but what now I hear you ask?

Tate and smile?

A Thursday in the middle of both a general corporate earnings disclosure frenzy and a market rout always throws up a few questionable share price reactions. I am wondering if one of these was the reaction by Tate & Lyle (TATE) shares which have fallen from 650p to around 600p at the time of writing.

Donald and Mexico. Will It Strike a Sour Note with Sugary Giant Tate and Lyle?

Hello Share Crashers. It seems to me that there is a headwind against the over-consumption of sugar. The Government warns against eating too much and so do all sorts of health writers. And when what you sell is under scrutiny, then you have to be concerned about future profits.

Tate & Lyle (#TATE) – “strong start” to year, if current FX continues “reported earnings would increase strongly”

Tate & Lyle (#TATE) trading statement - says will hit forecasts

Tate & Lyle (#TATE) for once a trading statement that is NOT a profits warning - in line

Tate & Lyle (#TATE) Trading Statement Dull, but no worse than last time

Drowning in debt Tate & Lyle (#TATE) issues yet another profits warning

Buy Tate & Lyle if it moves through 670.5p

Shares in sweetener specialist Tate & Lyle (TATE) are currently forming a classic MIDAS pattern. A buy signal was triggered on Wednesday, as this stock closed bang on MIDAS support. Since then the shares have pulled back, leaving MIDAS users with a tricky decision. Currently trading at 666p, this is below the projected AUG2010 support at 670.56p and the question is whether the stock can build on its recent consolidation.

Tate & Lyle is undervalued

Tate & Lyle (TATE) yesterday reported first-half pretax profit £130m and a bullish outlook for the second half. Strong sales in Speciality Food Ingredients and growth in emerging markets should support the share price going forward. The company has a good track record when it comes to delivering earnings and dividend in line or above expectations.